尊龙凯时
About us
尊龙凯时:Our Values
尊龙凯时:Development Milestone
Products
尊龙凯时:Product List for API
尊龙凯时:Recommended API
尊龙凯时:Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
尊龙凯时:Contract Manufacturing
尊龙凯时:API and Pharmaceutical Intermediates
尊龙凯时:OTC and Generics
尊龙凯时:Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
尊龙凯时:Contact Us
About us
News
尊龙凯时:Investor Relation
Products
尊龙凯时:Contract Manufacturing
尊龙凯时:Contact Us
Investor Relation
Investor Relation
尊龙凯时:PERIODIC REPORT
尊龙凯时:INTERIM REPORT
尊龙凯时:INVESTORS SERVICE
(1) CONTINUING CONNECTED TRANSACTIONS(2) PROPOSED ADOPTION OF SHARE OPTION SCHEM
2018-12-11
SUBMISSION OF BIDDING APPLICATION IN OPEN TENDER FOR ACQUIRING EQUITY INTEREST I
2018-12-05
Overseas Regulatory Announcement
2018-12-05
CONNECTED TRANSACTION
2018-11-30
UPDATE ON PROPOSED CHANGE OF SHAREHOLDING STRUCTURE OF CONTROLLING SHAREHOLDER
2018-11-26
Overseas Regulatory Announcement
2018-11-26
Overseas Regulatory Announcement
2018-11-19
NOTICE OF EXTRAORDINARY GENERAL MEETING AND OF MEETING OF THE SHAREHOLDERS OF H
2018-11-12
Reply Slip for Extraordinary General Meeting
2018-11-12
Reply Slip for the Class Meeting of H Shareholders
2018-11-12
<
...
23
24
25
26
27
28
29
...
>